See more : Sparinvest INDEX Høj Risiko KL (SPVIHRKL.CO) Income Statement Analysis – Financial Results
Complete financial analysis of Lucy Scientific Discovery Inc. (LSDI) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Lucy Scientific Discovery Inc., a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- PT Star Pacific Tbk (LPLI.JK) Income Statement Analysis – Financial Results
- Mostostal Warszawa S.A. (MSW.WA) Income Statement Analysis – Financial Results
- Ormonde Mining plc (ORM.L) Income Statement Analysis – Financial Results
- Gujarat Themis Biosyn Limited (GUJTHEM.BO) Income Statement Analysis – Financial Results
- Bonterra Resources Inc. (BONXF) Income Statement Analysis – Financial Results
Lucy Scientific Discovery Inc. (LSDI)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.lucyscientific.com
About Lucy Scientific Discovery Inc.
Lucy Scientific Discovery Inc. researches, develops, manufactures, and commercializes psychedelic products. It offers biological raw materials, crude extracts, psychotropic compounds, and active pharmaceutical ingredients (APIs). Lucy Scientific Discovery Inc. was formerly known as Hollyweed North Cannabis, Inc. The company was incorporated in 2017 and is based in Victoria, Canada.
Metric | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Revenue | 7.05K | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 4.50K | 0.00 | 0.00 | 0.00 |
Gross Profit | 2.55K | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 36.15% | 0.00% | 0.00% | 0.00% |
Research & Development | 0.00 | 0.00 | 165.83K | 61.20K |
General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.77M | 3.47M | 2.68M | 2.80M |
Other Expenses | 53.00 | 136.00 | -165.83K | 0.00 |
Operating Expenses | 5.77M | 3.47M | 2.51M | 2.86M |
Cost & Expenses | 5.77M | 3.47M | 2.51M | 2.86M |
Interest Income | 1.97M | 2.06M | 2.36M | 283.28K |
Interest Expense | 1.97M | 2.06M | 2.36M | 171.75K |
Depreciation & Amortization | 101.47K | 322.23K | 236.56K | 206.30K |
EBITDA | -5.66M | -3.47M | -2.49M | -2.86M |
EBITDA Ratio | -80,360.58% | 0.00% | 0.00% | 0.00% |
Operating Income | -5.84M | -3.79M | -2.49M | -2.86M |
Operating Income Ratio | -82,919.74% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | -3.22M | -2.39M | -2.21M | -699.53K |
Income Before Tax | -8.99M | -5.86M | -4.73M | -3.56M |
Income Before Tax Ratio | -127,532.01% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 1.97M | 322.23K | 2.38M | -559.73K |
Net Income | -8.99M | -6.18M | -7.10M | -3.00M |
Net Income Ratio | -127,532.01% | 0.00% | 0.00% | 0.00% |
EPS | -0.71 | -0.38 | -0.44 | -0.19 |
EPS Diluted | -0.71 | -0.38 | -0.44 | -0.19 |
Weighted Avg Shares Out | 12.70M | 16.06M | 16.06M | 16.06M |
Weighted Avg Shares Out (Dil) | 12.70M | 16.06M | 16.06M | 16.06M |
Lucy Scientific Discovery Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Why Is Lucy Scientific Discovery (LSDI) Stock Up 227% Today?
Lucy Scientific Discovery Inc. Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement
Lucy Scientific Discovery's Alternative Mental Health Treatments to Provide Opportunity to Improve Mental Health
Lucy Scientific Discovery (NASDAQ: LSDI) Acquisitions Create ‘Golden Opportunity' for Growth, Success
Lucy Scientific Discovery (NASDAQ: LSDI) Leverages Power of M&A to Capitalize on Synergistic Growth
Lucy Scientific Discovery Expands its Reach in the Global Wellness Market with BlueSky Wellness Acquisition
Lucy Scientific Discovery Inc. Announces Acquisition of BlueSky Wellness Inc. in All-Stock Transaction
Lucy Scientific Discovery Inc. (NASDAQ: LSDI) Acquisition Strategy Differentiates Company in Projected $51B Global Cannabis Market
Lucy Scientific Acquires High Times Intellectual Property, Including Existing Licensing Agreements in All-Stock Transaction
Source: https://incomestatements.info
Category: Stock Reports